Plain-English translation of NCT06076538 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial tests whether a combined imaging scan called PET/MR can better help doctors understand kidney masses that are found by chance during routine imaging. Right now, doctors sometimes struggle to know if a kidney mass is cancer or harmless, which can lead to unnecessary surgeries. This study aims to see if this advanced imaging technique can give clearer answers.
About 20% of small kidney masses turn out to be benign (harmless), and many cancers found this way grow very slowly and may never harm you. Yet many patients undergo surgery or other treatments they may not actually need. This trial exists to develop better imaging tools that can tell the difference between dangerous and harmless masses, so patients only get treated when truly necessary.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo a special combined imaging scan called PET/MR, which takes detailed pictures of your kidney mass. You will then be managed according to standard care — meaning your doctor will follow their usual recommendations for your situation. The study is observational, meaning researchers are watching and learning from your imaging and follow-up care, but you are not receiving an experimental treatment.
AI-generated summary from trial data · Aug 16, 2026 · Not medical advice
United States